SCHEMBL20129030

SCHEMBL20129030

CC(C)(C)OC(=O)n1c2ccncc2c2c(F)c(F)c(-c3ccc(OCCOCCOCCOCCOCCO)nc3)cc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 2/20 0.36
GCK P35557 4/20 0.35
GABRG2 P18507 2/20 0.35
GABRB3 P28472 2/20 0.35
GABRA5 P31644 2/20 0.35
SYK P43405 1/20 0.34
GABRA1 P14867 1/20 0.33
GABRA2 P47869 1/20 0.33
GABRA6 Q16445 1/20 0.33
BTK Q06187 1/20 0.33
PTGDR2 Q9Y5Y4 1/20 0.32
RAF1 P04049 1/20 0.32
BRAF P15056 1/20 0.32
CSNK2A1 P68400 2/20 0.32
RPS6KA3 P51812 1/20 0.32
CSNK2A2 P19784 1/20 0.32
GPBAR1 Q8TDU6 1/20 0.32
GPR119 Q8TDV5 2/20 0.31
DGAT1 O75907 1/20 0.31
SLC22A12 Q96S37 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27097797 0.92 PTGES (0.36) NR1H2GABRG2GABRB3GABRA5GABRA1
SCHEMBL20129031 0.90 BTK (0.35) NR1H2GABRG2GABRB3GABRA5GABRA1
SCHEMBL27098483 0.84 NR1H2 (0.38) NR1H2GCKGABRG2GABRB3GABRA5
SCHEMBL29773812 0.84 NR1H2 (0.38) NR1H2GCKGABRG2GABRB3GABRA5
SCHEMBL20120812 0.84 NR1H2 (0.38) NR1H2GCKGABRG2GABRB3GABRA5
SCHEMBL29547450 0.84 NR1H2 (0.38) NR1H2GCKGABRG2GABRB3GABRA5
SCHEMBL27098412 0.84 NR1H2 (0.38) NR1H2GCKGABRG2GABRB3GABRA5
SCHEMBL20129032 0.80 BRD9 (0.44)
SCHEMBL20129203 0.79 NR1H2 (0.41) NR1H2GCKGABRG2GABRB3GABRA5
SCHEMBL20128937 0.75 GPR119 (0.34) NR1H2GABRG2GABRB3GABRA5GABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11912699-B2 Tau-protein targeting compounds and associated ARVINAS OPERATIONS, INC. (US) 2024-02-27 US disclosed
US-20180125821-A1 TAU-PROTEIN TARGETING PROTACS AND ASSOCIATED METHODS OF USE ARVINAS OPERATIONS, INC. 2018-05-10 US disclosed
US-20180125821-A1 TAU-PROTEIN TARGETING PROTACS AND ASSOCIATED METHODS OF USE ARVINAS OPERATIONS, INC. 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11912699-B2 Tau-protein targeting compounds and associated MAPT, VHL, CRBN NR1H2 3409/4885GCK 4358/4885GABRG2 2138/4885
US-20180125821-A1 TAU-PROTEIN TARGETING PROTACS AND ASSOCIATED METHODS OF USE CRBN, VHL, UBQLN2 NR1H2 3751/4885GCK 4327/4885GABRG2 2336/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.